Skip to main content
. 2019 Aug 31;8(17):e013204. doi: 10.1161/JAHA.119.013204

Figure 1.

Figure 1

Study flow chart of the patient enrollment. ACEi indicates angiotensin‐converting‐enzyme inhibitor; AF, atrial fibrillation; AFCA, AF catheter ablation; ARB, angiotensin type II receptor blocker; eGFR, estimated glomerular filtration rate.